El-Nile is an Egyptian state-sector drug maker whose profit more than doubled in its latest fiscal year. The gain came with a sharp note from the state auditor, which is worth understanding before the headline number. Full nameEl-Nile Co. For Pharmaceuticals And Chemical Industries Tickers / exchangeNIPH.EGX — Egyptian Exchange (EGX) HeadquartersCairo, Egypt (city not confirmed in primary filings reviewed) SectorPharmaceuticals and chemicals EmployeesNot published in sources reviewed Market valueNot published in sources reviewed Yearly sales≈ EGP 2.134 billion (≈ US$40.8 million), FY ended 30 June 2026 Net profitEGP 256,369,688 …
El-Nile Co. For Pharmaceuticals And Chemical Industries
·
September 5, 2026
·
4 min read
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →